Search Results Search Sort by RelevanceMost Recent Viewpoint Sep 2007 Gamete Donation, Identity, and the Offspring's Right to Know Lucy Frith The ethical reasons for making gamete donation nonanonymous and allowing offspring to have access to donor information. Virtual Mentor. 2007;9(9):644-648. doi: 10.1001/virtualmentor.2007.9.9.oped1-0709. Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 2 Antonella Surbone, MD, PhD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006;8(1):10-15. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601. Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 1 Heidi Malm, PhD and Gerald W. Chodak, MD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006;8(1):7-10. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601. History of Medicine Aug 2006 Lessons in Dermatology Research: Protecting Vulnerable Research Participants T. Howard Stone, JD, LLM A historical look at dermatological testing and the regulations that have been enacted to protect the patients who test skin care products. Virtual Mentor. 2006;8(8):533-537. doi: 10.1001/virtualmentor.2006.8.8.mhst1-0608. Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 1 Matthew R. Golden, MD, MPH and Matthew Hogben, PhD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-715. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811. Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 2 Mark A. Levine, MD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-718. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811. Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. In the Literature Nov 2004 Maintaining Integrity in Industry-Sponsored Research Alison Bickford Many ethical and legal issues arise when academic medical research is sponsored by pharmaceutical companies. Virtual Mentor. 2004;6(11):490-493. doi: 10.1001/virtualmentor.2004.6.11.jdsc2-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Page 13 Next page Next › Last page Last »
Viewpoint Sep 2007 Gamete Donation, Identity, and the Offspring's Right to Know Lucy Frith The ethical reasons for making gamete donation nonanonymous and allowing offspring to have access to donor information. Virtual Mentor. 2007;9(9):644-648. doi: 10.1001/virtualmentor.2007.9.9.oped1-0709.
Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 2 Antonella Surbone, MD, PhD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006;8(1):10-15. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601.
Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 1 Heidi Malm, PhD and Gerald W. Chodak, MD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006;8(1):7-10. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601.
History of Medicine Aug 2006 Lessons in Dermatology Research: Protecting Vulnerable Research Participants T. Howard Stone, JD, LLM A historical look at dermatological testing and the regulations that have been enacted to protect the patients who test skin care products. Virtual Mentor. 2006;8(8):533-537. doi: 10.1001/virtualmentor.2006.8.8.mhst1-0608.
Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 1 Matthew R. Golden, MD, MPH and Matthew Hogben, PhD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-715. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811.
Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 2 Mark A. Levine, MD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-718. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
In the Literature Nov 2004 Maintaining Integrity in Industry-Sponsored Research Alison Bickford Many ethical and legal issues arise when academic medical research is sponsored by pharmaceutical companies. Virtual Mentor. 2004;6(11):490-493. doi: 10.1001/virtualmentor.2004.6.11.jdsc2-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.